# Limited additional value of dual-layer spectral 4DCT compared with conventional 4DCT for preoperative localization in primary hyperparathyroidism

**Authors:** Jorian P. Krol, Tessa Veerbeek, Laura N. Deden, Frank B.M. Joosten, Marie Louise E. Bernsen, Cornelis H. Slump, Wim J.G. Oyen

PMC · DOI: 10.1016/j.ejro.2025.100669 · 2025-06-24

## TL;DR

This study finds that dual-layer spectral 4DCT does not offer significant advantages over conventional 4DCT for locating parathyroid adenomas before surgery.

## Contribution

The study is the first to evaluate dual-layer spectral 4DCT for preoperative localization in primary hyperparathyroidism in a larger patient cohort.

## Key findings

- Conventional CT reconstructions outperformed spectral reconstructions in differentiating thyroid from parathyroid tissue.
- No significant difference was found between conventional and spectral CT in distinguishing lymph nodes from parathyroid tissue.
- Virtual non-contrast reconstructions showed lower accuracy compared to true non-contrast scans.

## Abstract

Primary hyperparathyroidism, characterized by excessive parathyroid hormone secretion, is typically caused by solitary parathyroid adenomas or multiglandular disease. Accurate preoperative localization is critical for successful surgical parathyroidectomy. While four-dimensional CT (4DCT) is commonly used for this purpose, spectral-CT techniques have recently been introduced, offering improved tissue differentiation. Rapid kV switching and dual-source spectral-CT have been studied, however, this is the first study that evaluates the effectiveness of dual-layer-CT in preoperatively locating parathyroid adenomas in a larger population.

From April 2020 to October 2023, patients with confirmed primary hyperparathyroidism underwent dual-layer spectral 4DCT before surgery. Spectral reconstructions (MonoE40keV, Iodine-Density, Z-effective, Iodine-no-Water, Virtual Non-Contrast) were analyzed alongside conventional CT reconstructions. Mean attenuation values were compared using one-way ANOVA. ROC curves with paired-sample analysis assessed the ability of different reconstructions to distinguish between thyroid and parathyroid tissue, and lymph nodes and parathyroid tissue.

Thirty-six patients with thirty-nine parathyroid adenomas were analyzed. Conventional CT reconstructions demonstrated significantly higher AUC values for differentiating thyroid from parathyroid tissue across all phases compared to spectral reconstructions (0.83–0.95 vs. 0.65–0.89, p-value 0.007-<0.001). No significant difference was found between conventional and spectral reconstructions in distinguishing lymph nodes from parathyroid tissue (0.64–0.96 vs. 0.58–0.96, p-value 0.070–0.957). Virtual non-contrast (VNC) reconstructions showed smaller attenuation differences and lower AUC values in arterial and delayed phases compared to true non-contrast (p = 0.031 and 0.034).

Dual-layer spectral-CT is comparable or inferior to conventional CT in tissue differentiation. VNC reconstructions are not recommended as a substitute for true non-contrast due to inconsistent results. In this cohort, dual-layer spectral 4DCT did not demonstrate clear clinical advantage; further validation is warranted.

## Linked entities

- **Diseases:** primary hyperparathyroidism (MONDO:0010837)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** multiglandular disease (MESH:D004194), lymph (MESH:D000072717), parathyroid adenomas (MESH:D010282), Primary hyperparathyroidism (MESH:D049950)
- **Chemicals:** Iodine (MESH:D007455), Water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12241994/full.md

---
Source: https://tomesphere.com/paper/PMC12241994